# Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis

> **NCT00462020** · NA · COMPLETED · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 102 (actual)

## Conditions studied

- Perforated Appendicitis

## Interventions

- **DRUG:** 5 days of IV antibiotics (ceftriaxone and metronidazole)
- **DRUG:** Home with oral antibiotics when eating (ampicillin/clavulanic acid)

## Key facts

- **NCT ID:** NCT00462020
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462020, "Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00462020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*